My SciELO
Services on Demand
Journal
Article
Indicators
Cited by SciELO
Access statistics
Related links
Cited by Google
Similars in SciELO
Similars in Google
Share
Sanidad Militar
Print version ISSN 1887-8571
Abstract
GARCIA-LUQUE, A; SILVA-CUEVAS, MA; GRANDA-LOBATO, P and CORREA-PEREZ, A. Positive assessment of drugs: July, September and October of 2022. Sanid. Mil. [online]. 2022, vol.78, n.4, pp.261-267. Epub June 26, 2023. ISSN 1887-8571. https://dx.doi.org/10.4321/s1887-857120220004000010.
SUMMARY: The drugs assessed by the European Medicines Agency made public in July, September and October of 2022, and considered of interest to the healthcare professional, are reviewed. These are positive technical reports prior to the authorization and placing on the market of the product.
Keywords : Abaloparatida (Eladynos®); Espesolimab (Spevigo®); Faricimab (Vabysmo®); Fosdenopterina (Nulibry®); Gozetotida (Locametz®); Loncastuximab tesirina (Zynlonta®); Maralixibat (Livmarli®); Maribavir (Livtencity®); Mitapivat (Pyrukynd®); Nirsevibab (Beyforuts®); Nivolumab/Relatlimab (Opdualag®); Sutimlimab (Enjaymo®); Tabelecleucel (Ebvallo®); Teclistamab (Tecvayli®); Tezepelumab (Tezspire®); Tirzepatida (Mounjaro®); Vacuna tetravalente contra el dengue (Qdenga ®); Vipivotida tetraxetan lutecio (177LU) (Pluvicto®); Voclosporina (Lupkynis®); Vutrisiran (Amvuttra ®).